⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL634334 | 0.97 | SHBG (0.56) | — | |
| SCHEMBL12094462 | 0.94 | — | — | |
| SCHEMBL19539461 | 0.88 | — | — | |
| SCHEMBL9971146 | 0.74 | SHBG (0.43) | — | |
| SCHEMBL19799387 | 0.72 | — | — | |
| SCHEMBL16864424 | 0.72 | EPHX1 (0.35) | — | |
| SCHEMBL16026654 | 0.72 | SHBG (0.41) | — | |
| SCHEMBL28027504 | 0.72 | SHBG (0.30) | — | |
| SCHEMBL18951345 | 0.71 | SHBG (0.36) | — | |
| SCHEMBL2342491 | 0.71 | SHBG (0.57) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2348023-B9 | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors | INCYTE HOLDINGS CORP (US) | 2017-03-08 | — | — | EP | disclosed |
| US-20030055297-A1 | An alkyl, cycloalkyl, arylalkyl dihydroxy compound useful as intermediates; a cost-effective preparation | ABBOTT LABORATORIES | 2003-03-20 | — | — | US | disclosed |
| WO-2002081441-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRROLIDINE NEURAMINIDASE INHIBITORS | ABBOTT LABORATORIES (US) | 2002-10-17 | — | — | WO | disclosed |
| EP-0858340-A4 | COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND OBESITY | MERCK & CO INC (US) | 1999-12-29 | — | — | EP | disclosed |
| EP-0858340-A1 | COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND OBESITY | Merck & Co., Inc. (US) | 1998-08-19 | — | — | EP | disclosed |
| WO-1997016189-A1 | COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND OBESITY | MERCK & CO., INC. (US) | 1997-05-09 | — | — | WO | disclosed |